How To Balance Risk Of Escape Of New H5N1 Viruses With Benefits Of Research

In the controversy surrounding the newly developed strains of avian H5N1 flu viruses, scientists and policy makers are struggling with one question in particular: what level of biosafety is best for studying these potentially lethal strains of influenza? In a pair of commentaries, researchers from the Mount Sinai School of Medicine in New York and the University of Michigan arg...

Source: http://www.medicalnewstoday.com/releases/242548.php

CA, INC. FISERV, INC. SANDISK CORPORATION BROADCOM CORPORATION